Paul applies chemical, physical and biological principles to study and develop genome editing technologies. He hopes his work will help to realize the therapeutic potential of genome editing.

During his PhD in chemical engineering and applied chemistry, Paul developed methods to study and control the structure of nanoparticles, advancing our understanding of how atoms build materials. These insights have expanded our capabilities for nanoparticle design and enabled potential nanotechnology applications in medicine and clean energy.

As a Schmidt Science Fellow, Paul pivoted to bioengineering and molecular biology at The Broad Institute of MIT and Harvard, where he explored using genome editing to correct DNA mutations causing genetic diseases. He continues his work as a Postdoctoral researcher.